# CLBT — AI stock forecast & analysis

> AI-generated analysis by K3vl4r — 2026-07-31. Informational only, not financial advice.

**Recommendation:** ACCUMULATE

**Scores (0–100):** Overall 6.7 · Fundamentals 7.6 · Technicals 6.7 · Growth 7.8 · Risk 5.8

## Summary

Cellebrite (CLBT) shows resilient fundamentals with strong gross margins and healthy cash flow, but recent insider selling and a 3.32% daily drop signal near-term caution. The Kronos forecast suggests potential upside within its bands, though valuation remains elevated at 51x P/E. Short-term catalysts include earnings on August 13, while long-term growth hinges on expanding AI-driven forensic solutions.

## Price targets (6-month horizon)

- Bear: $12.75
- Base: $16.85
- Bull: $22.00

## News context

Recent news highlights CEO Hogan's tax-driven share sale (103k shares) and DA Davidson's bullish thesis on CLBT's large TAM, but the stock has dropped 3.32% in 24h. The Kronos forecast shows a potential upside to $15.215, though insider selling adds near-term caution. The company's strong gross margins (83.86%) and healthy cash flow ($172.55M) support long-term growth despite valuation concerns.

## About
- Methodology: https://app.k3vl4r.com/methodology
- Full report: https://app.k3vl4r.com/r/clbt-ai-stock-forecast-e32f470a21ad1de12ff3a8401831bfb6
- AI-generated; model outputs can be wrong. Not financial advice.